Swiss National Bank
ADPT icon

Swiss National Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Swiss National Bank’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97M Buy
231,700
+6,500
+3% +$99.6K ﹤0.01% 1463
2026
Q1 		$3.13M Hold
225,200
– – ﹤0.01% 1615
2025
Q4 		$3.66M Buy
225,200
+19,100
+9% +$312K ﹤0.01% 1536
2025
Q3 		$3.08M Buy
206,100
+6,000
+3% +$73.1K ﹤0.01% 1617
2025
Q2 		$2.33M Hold
200,100
– – ﹤0.01% 1710
2025
Q1 		$1.49M Sell
200,100
-3,000
-1% -$23.1K ﹤0.01% 1937
2024
Q4 		$1.22M Buy
+203,100
New +$1.12M ﹤0.01% 2113
2024
Q2 		– Sell
-199,600
Closed -$641K – 2460
2024
Q1 		$641K Hold
199,600
– – ﹤0.01% 2401
2023
Q4 		$978K Sell
199,600
-22,500
-10% -$103K ﹤0.01% 2251
2023
Q3 		$1.21M Buy
222,100
+3,800
+2% +$25.1K ﹤0.01% 2131
2023
Q2 		$1.46M Buy
218,300
+2,300
+1% +$17.1K ﹤0.01% 2087
2023
Q1 		$1.91M Sell
216,000
-25,500
-11% -$225K ﹤0.01% 1868
2022
Q4 		$1.85M Buy
241,500
+5,400
+2% +$42K ﹤0.01% 1945
2022
Q3 		$1.68M Buy
236,100
+2,600
+1% +$24.5K ﹤0.01% 1993
2022
Q2 		$1.89M Buy
233,500
+16,600
+8% +$146K ﹤0.01% 1958
2022
Q1 		$3.01M Buy
216,900
+15,300
+8% +$241K ﹤0.01% 1780
2021
Q4 		$5.66M Hold
201,600
– – ﹤0.01% 1379
2021
Q3 		$6.85M Buy
201,600
+2,100
+1% +$76K ﹤0.01% 1239
2021
Q2 		$8.15M Sell
199,500
-3,600
-2% -$140K 0.01% 1149
2021
Q1 		$8.18M Buy
203,100
+3,500
+2% +$189K 0.01% 1116
2020
Q4 		$11.8M Buy
199,600
+27,000
+16% +$1.39M 0.01% 843
2020
Q3 		$8.39M Buy
172,600
+3,400
+2% +$143K 0.01% 885
2020
Q2 		$8.19M Buy
+169,200
New +$6.17M 0.01% 871

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Swiss National Bank's ADPT Position: Q2 2026 in Review

Swiss National Bank increased its Adaptive Biotechnologies (ADPT) stake by 2.9% in Q2 2026, buying an estimated $99.6K and bringing the position to 231,700 shares worth $4.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1463.

Swiss National Bank first reported a position in ADPT in Q2 2020 and has held it in 23 quarters since. The position peaked at $11.8M in Q4 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Swiss National Bank held 231,700 shares of Adaptive Biotechnologies worth $4.97M as of Q2 2026.
  • Swiss National Bank bought 6,500 Adaptive Biotechnologies shares in Q2 2026, an estimated $99.6K.
  • Adaptive Biotechnologies made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1463 holding.
  • Swiss National Bank first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 23 quarters since.
  • Swiss National Bank's Adaptive Biotechnologies position peaked at $11.8M in Q4 2020.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.